Hepatocyte growth factor (FGF) and its high affinity tyrosine kinase receptor, c-met, are important mediators of mesenchymal/epithelial interactions and tubulogenesis during renal development, as well as maintenance and repair of tubular architecture in the adult kidney. A clear understanding of the mechanisms by which c-met activates these cellular events may aid in understanding developmental abnormalities of the renal tubules (such as cystic kidney diseases) as well as providing insight into events leading to tubular repair vs. scarring following renal injury. We have found that the chemotactic and tubulogenic actions of the c-met receptor require activation of the phosphatidylinositol 3-kinase (PI 3-K). Most recently we have exciting new data which demonstrates that the PI- 3,4,5-P3 lipid product of the PI 3-K is capable of directly initiating chemotaxis, for the first time demonstrating an in vivo role for this lipid as a member of a novel class of second messengers. To further characterize the subcellular events in c-met mediated epithelial morphogenesis, we will focus this research on two major areas. First wei will extensively examine the role of the PI 3-K in chemotaxis and tubulogenesis by: 1) determining the signalling events initiated by the novel second messenger PIP3 (Specific Aim 1a), and 3) elucidating the role of the p85 and p110 subunits of the PI 3-K in morphogenesis using a series of deletional mutants of the enzyme (Specific Aim 1b). Additional pathways required for normal epithelial chemotaxis and tubulogenesis will be identified by isolating a met-/-cell line followed by transfection of met receptor mutants which selectively associate with candidate signaling proteins identified in this proposal (Specific Aim 2a) as well as determination of the kinase specificity of c-met (Specific Aim 2b). The long term goals of this proposal are to identify which signaling pathways are critical for HGF/c-met-dependent cell changes, and to pursue means in which to intervene in these events so as to enhance recovery from renal tubular injury or promote normal renal tubular development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK048871-02
Application #
2391492
Study Section
General Medicine B Study Section (GMB)
Project Start
1996-04-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
O'Rourke, D A; Liu, Z X; Sellin, L et al. (2000) Hepatocyte growth factor induces MAPK-dependent formin IV translocation in renal epithelial cells. J Am Soc Nephrol 11:2212-21
O'Rourke, D A; Sakurai, H; Spokes, K et al. (1999) Expression of c-ret promotes morphogenesis and cell survival in mIMCD-3 cells. Am J Physiol 276:F581-8
Roshan, B; Kjelsberg, C; Spokes, K et al. (1999) Activated ERK2 interacts with and phosphorylates the docking protein GAB1. J Biol Chem 274:36362-8
Rameh, L E; Rhee, S G; Spokes, K et al. (1998) Phosphoinositide 3-kinase regulates phospholipase Cgamma-mediated calcium signaling. J Biol Chem 273:23750-7
Bae, Y S; Cantley, L G; Chen, C S et al. (1998) Activation of phospholipase C-gamma by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:4465-9
Joannidis, M; Cantley, L G; Spokes, K et al. (1997) Modulation of c-fos and egr-1 expression in the isolated perfused kidney by agents that alter tubular work. Kidney Int 52:130-9
Sakurai, H; Tsukamoto, T; Kjelsberg, C A et al. (1997) EGF receptor ligands are a large fraction of in vitro branching morphogens secreted by embryonic kidney. Am J Physiol 273:F463-72
Derman, M P; Toker, A; Hartwig, J H et al. (1997) The lipid products of phosphoinositide 3-kinase increase cell motility through protein kinase C. J Biol Chem 272:6465-70